Insulin treatment could help those with diabetes maintain independent living arrangements |
|
|
|
| Wednesday, 26 August 2009 15:04 |
|
Diabetes can affect many people in independent living communities and other retirement communities, since approximately half of all diabetes cases are diagnosed in people aged 60 or older, according to the Centers for Disease Control and Prevention. Concerns over insulin-based treatments has led some patients to question its viability as a therapy, but a new study from UT Southwestern Medical Center suggests that for diabetes patients looking to maintain an independent living situation, it may be the best front-line option. Researchers there followed patients aged 21 to 70 who had recently been diagnosed with type 2 diabetes, and found that after three months, side effects such as weight gain did not occur in those who had been taking insulin compared to other treatments. "There is a myth out in the community... that insulin is the last resort, and that somebody started on insulin is going to die," said lead researcher Dr Ildiko Lingvay. "We as physicians are responsible for teaching the patient that that's not the case."Instead, Lingvay and the rest of the study's team advocate that with easier-to-use insulin options available, patients should be using them more frequently. © Copyright |
Related Articles
When it comes to Alzheimer’s disease, the good news is that the last few decades have seen an explosion in fundamental scientific knowledge about what causes Alzheimer’s and what happens as the disease progresses. Progress has been made on a number of fronts, according to the Alzheimer's Disease Education and Referral (ADEAR) Center:
Read more...
For those on fixed incomes, Eli Lilly Pharmaceuticals has expanded its patient assistance program to cover couples who make up to $44,000 annually, or at least 300 percent times federal rates for poverty.
Most of the drugmaker's portfolio is made available to consumers who enroll in the program at little or no cost, and contributed more than $800 million in prescripton drugs over the previous three years when it was limited to those making 200 percent or less of federal poverty levels.
Both pharmaceutical firms and other companies, like Wal-Mart, have begun or expanded efforts to increase the availability of medications to those in need since the economic downturn last fall.
"By making these changes, we are addressing a real concern for patients we have heard from in recent months," said Dr John Lechleiter, Eli Lilly chairmain, president and CEO.
Read more...
At Washington University in St Louis, doctors worked
Read more...

Join the Discussion Have something you want to discuss, tips to share or a question to ask? Join the Health and Wellness Discussion Group |
|
|



that insulin is the last resort, and that somebody started on insulin is going to die," said lead researcher Dr Ildiko Lingvay. "We as physicians are responsible for teaching the patient that that's not the case."

Comments (0)